US 12,263,343 B2
Neurostimulator with titration assist
Scott Stubbs, Maple Grove, MN (US); Imad Libbus, St. Paul, MN (US); Scott Mazar, Woodbury, MN (US); Bruce H. KenKnight, Maple Grove, MN (US); and Badri Amurthur, Los Gatos, CA (US)
Assigned to LivaNova USA, Inc., Houston, TX (US)
Filed by LivaNova USA, Inc., Houston, TX (US)
Filed on Aug. 15, 2023, as Appl. No. 18/234,186.
Application 18/234,186 is a continuation of application No. 17/503,094, filed on Oct. 15, 2021, granted, now 11,745,015.
Application 17/503,094 is a continuation of application No. 16/185,838, filed on Nov. 9, 2018, granted, now 11,147,972.
Application 16/185,838 is a continuation of application No. 15/181,177, filed on Jun. 13, 2016, granted, now 10,124,170.
Prior Publication US 2023/0398358 A1, Dec. 14, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01)
CPC A61N 1/36114 (2013.01) [A61N 1/36053 (2013.01); A61N 1/36139 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator, the method comprising:
titrating the neurostimulation signal from a first set of parameters toward a target set of parameters according to a titration aggressiveness profile having a titration hold point corresponding to a holding set of stimulation parameters, the holding set of stimulation parameters being a point in the titration aggressiveness profile at which the implantable pulse generator is configured to hold titration until a titration resumption is received from an external device;
receiving a hold indicator indicating that the titration has reached the holding set of stimulation parameters;
initiating an intermediate hold of the titrating of the neurostimulation signal in response to receiving the hold indicator; and
receiving an indication of a titration resumption from the external device that discontinues the intermediate hold.